Corporate Profile
| Company Name |
Nipro Pharma Corporation |
|---|---|
| Capital |
8,669 million yen (as of May, 2023) |
| Representative |
Kenichi Nishida, Representative Director and President |
| Head Office |
3-26, Senriokashinmachi, Settsu City, Osaka, 566-8510, Japan |
| Established |
August 1, 1948 |
| Incorporated |
July 25, 1950 |
| Number of employees |
4,235 (as of March 2025) |
| Director & Auditor |
Kenichi Nishida, President Takahiro Oichi, Managing Director Kumiko Kusuyama, Managing Director Takashi Nakamichi, Director Hisanori Miyawaki, Director Koki Kanazawa, Director Tetsuhiro Mikami, Director Naoya Nishimura, Director Naoki Okamoto, Director Terutoshi Maeda, Outside Director Yoshiko Tanaka, Outside Director Takehito Yogo, Auditor (as of June 24,2025) |
| Operating Officer |
Koki Iwama, Operating Officer Susumu Kimura, Operating Officer Yasuo Nishida, Operating Officer Shohei Otani, Operating Officer Eiji Fukui, Operating Officer Kengo Yamada, Operating Officer Yuki Tanaka, Operating Officer Takashi Nishii, Operating Officer Mitsutaka Okoshi, Operating Officer (as of June 24,2025) |
| Main business |
Manufacturing, sales, importing and exporting of pharmaceutical products |
| Production Bases／ Analysis Center |
Odate, Ise, Kagamiishi, |
| Group Companies |
Nipro Corporation, |
| Subsidiary Company |
Nipro Pharma Vietnam Co.,Ltd., |
| Main Bank of Account |
Mizuho Bank,Ltd., Resona Bank,Limited, |
| A member of |
The Federation of Pharmaceutical Manufacturers' Associations of Japan |
